易康生物

Shanghai Yikang Biotech is a specialized biotechnology company focused on the in vitro diagnostics (IVD) market. The company develops and manufactures a comprehensive range of diagnostic reagents and automated analysis systems, utilizing advanced technologies such as chemiluminescence immunoassay (CLIA) and point-of-care testing (POCT). Its product portfolio addresses critical clinical needs in infectious disease screening, cardiac marker detection, tumor monitoring, and inflammatory response assessment. With a GMP-certified production base in Shanghai, Yikang Biotech provides integrated diagnostic solutions to hospitals, clinics, and research institutions across China. The company is committed to enhancing clinical decision-making through high-sensitivity and high-throughput diagnostic platforms.